Nano-X Imaging (NNOX) Cash & Current Investments (2019 - 2026)
Nano-X Imaging (NNOX) posted quarterly Cash & Current Investments of $44.2 million for Q1 2026, up 8.65% year-on-year from $40.7 million in Q1 2025, and down 10.68% on a QoQ basis from $49.5 million in Q4 2025.
Nano-X Imaging (NNOX) Cash & Current Investments (2019 - 2026) Analysis & Trends
Nano-X Imaging (NNOX) has reported Cash & Current Investments for 8 consecutive years, with $44.2 million the latest figure, recorded in Q1 2026.
- Quarterly Cash & Current Investments rose 8.65% year-over-year to $44.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $44.2 million (up 8.65% YoY) and the FY2025 annual result came in at $49.5 million, down 14.2% from the prior year.
- Cash & Current Investments fell to $44.2 million in Q1 2026 per NNOX's latest filing, from $49.5 million in the prior quarter.
- Over the last five years, Cash & Current Investments for NNOX reached as high as $47.8 billion in Q3 2022 and fell as low as $40.7 million in Q1 2025.
- A 5-year average of $6.0 billion and a median of $57.7 million in 2024 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2022 — Cash & Current Investments jumped 19260.33% — and 2023, when it plunged 99.8%.
- Year by year, Cash & Current Investments stood at $77.6 million in 2022, then climbed by 6.13% to $82.4 million in 2023, then slipped by 29.95% to $57.7 million in 2024, then decreased by 14.2% to $49.5 million in 2025, then decreased by 10.68% to $44.2 million in 2026.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $44.2 million, $49.5 million, and $45.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 1.12 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 2.29 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 3.12 Bn |
| 10 | Nano-X Imaging | 62,810.26 | -44.16 Mn | -2.59 Mn | 44.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.22 Mn |
| Dec 31, 2025 | 49.51 Mn |
| Sep 30, 2025 | 45.56 Mn |
| Jun 30, 2025 | 50.27 Mn |
| Mar 31, 2025 | 40.70 Mn |
| Dec 31, 2024 | 57.71 Mn |
| Sep 30, 2024 | 56.71 Mn |
| Jun 30, 2024 | 56.70 Mn |
| Mar 31, 2024 | 56.70 Mn |
| Dec 31, 2023 | 82.38 Mn |
| Sep 30, 2023 | 95.35 Mn |
| Jun 30, 2023 | 74.53 Mn |
| Mar 31, 2023 | 79.05 Mn |
| Dec 31, 2022 | 77.62 Mn |
| Sep 30, 2022 | 47.77 Bn |
| Jun 30, 2022 | 35.02 Bn |
| Mar 31, 2022 | 18.83 Bn |
| Dec 31, 2021 | 88.71 Mn |
| Sep 30, 2021 | 246.76 Mn |
| Jun 30, 2021 | 249.98 Mn |